Carlen A Yuen (Carlen Yuen)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Diffusion Weighted Imaging

Blood Brain Barrier

Top Venues

Biomarkers in medicine

Personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Carlen A Yuen, Melike Pekmezci, Silin Bao, Xiao-Tang Kong
Metastatic glioblastoma to the lungs: a case report and literature review. CNS oncology 13 (1) (2024)
Carlen A Yuen, Silin Bao, Xiao-Tang Kong
A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient. Biomarkers in medicine 18 (9) (2024)
Carlen A Yuen, Melike Pekmezci, Silin Bao, Xiao-Tang Kong
Metastatic glioblastoma to the lungs: a case report and literature review. CNS oncology 13 (1) (2024)
Carlen A Yuen, Silin Bao, Melike Pekmezci, Fan Mo, Xiao-Tang Kong
Pembrolizumab in an HIV-infected patient with glioblastoma. Immunotherapy (2024)
Carlen A Yuen, Silin Bao, Xiao-Tang Kong
A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient. Biomarkers in medicine 18 (9) (2024)
Carlen A Yuen, Silin Bao, Xiao-Tang Kong
A non-enhancing, T2 fluid-attenuated inversion recovery hyperintense, diffusion-restricting brainstem lesion in an EGFR tyrosine kinase inhibitor-treated non-small-cell lung cancer patient. Biomarkers in medicine 18 (9) (2024)
Carlen A Yuen, Silin Bao, Mya Sandi Aung, Rhea Shishodia, Xiao-Tang Kong
Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report. Personalized medicine 21 (2) (2024)
Carlen A Yuen, Melike Pekmezci, Silin Bao, Xiao-Tang Kong
Metastatic glioblastoma to the lungs: a case report and literature review. CNS oncology 13 (1) (2024)
Carlen A Yuen, Silin Bao, Mya Sandi Aung, Rhea Shishodia, Xiao-Tang Kong
Dabrafenib and steroids for the treatment of Erdheim-Chester disease with extensive CNS involvement: a case report. Personalized medicine (2024)
Carlen A Yuen, Kourosh Rezania, Thomas Kelly, Michael R Bishop
Clinical predictors of chimeric antigen receptor T-cell therapy neurotoxicity: a single-center study. Immunotherapy 13 (15) (2021)